DANIEL K SPIEGELMAN Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for DANIEL K SPIEGELMAN.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of DANIEL K SPIEGELMAN. DANIEL K SPIEGELMAN is a Senior Vice President and CFO in CV THERAPEUTICS INC ($CVTX) and a Director in MYRIAD GENETICS INC ($MYGN) and a EVP, Chief Financial Officer in BIOMARIN PHARMACEUTICAL INC ($BMRN) and a Director in Oncothyreon Inc. ($ONTY) and a Director in Relypsa Inc ($RLYP).
Address: CV THERAPEUTICS, INC. 3172 PORTER DRIVE PALO ALTO 94304 CA
Companies in which DANIEL K SPIEGELMAN is an Insider
BIOMARIN PHARMACEUTICAL INC
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of DANIEL K SPIEGELMAN: EVP, Chief Financial Officer
Holdings: 47,686 shares
Current Value: $4,239,762
Latest Transaction: Jun 07 2019
$BMRN Market Capitalization: $15.63B
$BMRN Previous Close: $88.91
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Cascadian Therapeutics, Inc.
Industry: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731]
Position of DANIEL K SPIEGELMAN: Director
Holdings: 0 shares
Latest Transaction: Mar 13 2018
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
CV THERAPEUTICS INC
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of DANIEL K SPIEGELMAN: Senior Vice President and CFO
Holdings: 1,524 shares
Latest Transaction: Apr 08 2004
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
MYRIAD GENETICS INC
Industry: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
Position of DANIEL K SPIEGELMAN: Director
Holdings: 20,562 shares
Current Value: $316,655
Latest Transaction: May 28 2021
$MYGN Market Capitalization: $1.13B
$MYGN Previous Close: $15.40
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Relypsa Inc
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of DANIEL K SPIEGELMAN: Director
Holdings: 2,250 shares
Latest Transaction: Sep 02 2016
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of DANIEL K SPIEGELMAN
Sentiment: All, BMRN, CASC, CVTX, MYGN, RLYP
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| May 28 2021 | MYGN | MYRIAD GENETICS IN ... | SPIEGELMAN DANIEL K | Director | Sell | D | 0.00 | 15,889 | 0 | 20,562 | 36.5 K to 20.6 K (-43.59 %) |
| Dec 07 2020 | MYGN | MYRIAD GENETICS IN ... | SPIEGELMAN DANIEL K | Director | Grant | A | 0.00 | 15,889 | 0 | 36,451 | 20.6 K to 36.5 K (+77.27 %) |
| May 28 2020 | MYGN | MYRIAD GENETICS IN ... | SPIEGELMAN DANIEL K | Director | Grant | A | 0.00 | 20,562 | 0 | 20,562 | 0 to 20.6 K |
| Jun 07 2019 | BMRN | BIOMARIN PHARMACEU ... | SPIEGELMAN DANIEL K | EVP, Chief Financia ... | Grant | A | 68.78 | 176 | 12,106 | 47,686 | 47.5 K to 47.7 K (+0.37 %) |
| Apr 03 2019 | BMRN | BIOMARIN PHARMACEU ... | SPIEGELMAN DANIEL K | EVP, Chief Financia ... | Sell | S | 89.00 | 13,473 | 1,199,097 | 47,510 | 61 K to 47.5 K (-22.09 %) |
| Mar 29 2019 | BMRN | BIOMARIN PHARMACEU ... | SPIEGELMAN DANIEL K | EVP, Chief Financia ... | Sell | S | 90.00 | 100 | 9,000 | 60,983 | 61.1 K to 61 K (-0.16 %) |
| Mar 26 2019 | BMRN | BIOMARIN PHARMACEU ... | SPIEGELMAN DANIEL K | EVP, Chief Financia ... | Payment of Exercise | F | 88.05 | 3,598 | 316,804 | 61,083 | 64.7 K to 61.1 K (-5.56 %) |